RESUMO
Canine separation anxiety is a common behavioral problem presented to veterinarians. Associated behaviors are distressing to both dog and owner, have the potential to disrupt the human-companion animal bond, and may lead to euthanasia. The results of this study demonstrate the clinical efficacy and safety of Reconcile (fluoxetine, 1 to 2 mg/kg/day [0.45 to 0.91 mg/lb/day]), in conjunction with behavior management, for the treatment of canine separation anxiety. The beef flavored chewable formulation was palatable to treated dogs and easy to administer. This study provides to veterinarians and owners valuable information about an effective separation anxiety treatment plan that combines use of Reconcile with behavior modification.
Assuntos
Antidepressivos de Segunda Geração/administração & dosagem , Ansiedade de Separação/tratamento farmacológico , Comportamento Animal , Doenças do Cão/tratamento farmacológico , Fluoxetina/administração & dosagem , Inibidores Seletivos de Recaptação de Serotonina/administração & dosagem , Administração Oral , Animais , Ansiedade de Separação/psicologia , Canadá , Doenças do Cão/psicologia , Cães , Método Duplo-Cego , Vínculo Humano-Animal , Humanos , Resultado do Tratamento , Estados UnidosRESUMO
This study was designed to evaluate the efficacy of a citronella bark collar and a new, scentless spray bark collar in a veterinary hospital or a similar kennel-type environment. Forty-one dogs were included in the study. The efficacy of each collar was evaluated independently in comparison to control as well as in a crossover design. Thirty of the dogs were evaluated with the citronella collar, with 76.7% showing a reduction in barking. Twenty-nine dogs were evaluated with the scentless collar, with 58.6% showing a reduction in barking. The improvement over the control collars was statistically significant with both the citronella and scentless collars.
